{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:33:26Z","timestamp":1787585606792,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160765"],"award-info":[{"award-number":["82160765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2025JJA140834"],"award-info":[{"award-number":["2025JJA140834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117058","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:03:20Z","timestamp":1782302600000},"page":"117058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Triptolide enhances lenvatinib sensitivity in hepatocellular carcinoma by regulating CERK-mediated sphingolipid-ferroptosis axis"],"prefix":"10.1016","volume":"186","author":[{"given":"Chuling","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyou","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"10504","key":"10.1016\/j.intimp.2026.117058_bb0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The lancet commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2026.117058_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000430","article-title":"Neoadjuvant and adjuvant systemic therapy in HCC: current status and the future","volume":"8","author":"Singal","year":"2024","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"10.1016\/j.intimp.2026.117058_bb0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10126","key":"10.1016\/j.intimp.2026.117058_bb0030","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2026.117058_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12032-020-01350-4","article-title":"Activation of the HGF\/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression","volume":"37","author":"Fu","year":"2020","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/0008-5472.CAN-22-0963","article-title":"METTL1-mediated m7G tRNA modification promotes Lenvatinib resistance in hepatocellular carcinoma","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.intimp.2026.117058_bb0045","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 Signaling in hepatocellular carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-020-01029-3","article-title":"STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib","volume":"14","author":"Zheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117058_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156824","article-title":"Ponicidin promotes ferroptosis to enhance treatment sensitivity in Lenvatinib-resistant hepatocellular carcinoma cells through regulation of KEAP1\/NRF2","volume":"143","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.intimp.2026.117058_bb0060","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.7150\/ijbs.107195","article-title":"Regulated cell death in Lenvatinib resistance of hepatocellular carcinoma: from molecular mechanisms to therapeutic strategies","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.117058_bb0065","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.32604\/or.2025.066440","article-title":"Novel strategies against hepatocellular carcinoma through lipid metabolism","volume":"33","author":"Yang","year":"2025","journal-title":"Oncol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117058_bb0070","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/med.21963","article-title":"Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi-active components combination","volume":"43","author":"Zhao","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"27","key":"10.1016\/j.intimp.2026.117058_bb0075","article-title":"A new strategy to fight metallodrug resistance: mitochondria-relevant treatment through mitophagy to inhibit metabolic adaptations of Cancer cells","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"6","key":"10.1016\/j.intimp.2026.117058_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","article-title":"Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer","volume":"22","author":"Labrie","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2026.117058_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000443404","article-title":"Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents","volume":"25","author":"Cragg","year":"2016","journal-title":"Med. Princ. Pract."},{"issue":"2","key":"10.1016\/j.intimp.2026.117058_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jaccao.2022.04.004","article-title":"How to treat renal cell carcinoma: the current treatment landscape and cardiovascular toxicities","volume":"4","author":"Castro","year":"2022","journal-title":"JACC CardioOncol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117058_bb0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11655-020-3428-5","article-title":"Multidisciplinary and comprehensive Chinese medicine for advanced non-small cell lung Cancer patients: a retrospective study of 855 cases","volume":"27","author":"Huang","year":"2021","journal-title":"Chin. J. Integr. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117058_bb0100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1039\/D0NP00054J","article-title":"Triptolide: reflections on two decades of research and prospects for the future","volume":"38","author":"Tong","year":"2021","journal-title":"Nat. Prod. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2026.117058_bb0105","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.apsb.2021.02.001","article-title":"Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy","volume":"11","author":"Yu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"30","key":"10.1016\/j.intimp.2026.117058_bb0110","doi-asserted-by":"crossref","first-page":"eadv6990","DOI":"10.1126\/sciadv.adv6990","article-title":"Engineering hybrid nanoparticles for targeted codelivery of triptolide and CYP3A4-siRNA against pulmonary metastatic melanoma","volume":"11","author":"Gu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2026.117058_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110346","article-title":"Codelivery of triptolide and IFN-\u03b3 to boost antitumor immunity for triple-negative breast cancer","volume":"120","author":"Cai","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117058_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and its derivatives as Cancer therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14410","article-title":"Triptolide inhibits proliferation and invasion of colorectal cancer cells by blocking Nrf2 expression","volume":"103","author":"Wang","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"3","key":"10.1016\/j.intimp.2026.117058_bb0130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.intimp.2011.01.012","article-title":"Triptolide and its expanding multiple pharmacological functions","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"16","key":"10.1016\/j.intimp.2026.117058_bb0135","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.7150\/ijms.121880","article-title":"Disrupting CARMA3 Signaling with triptolide reverses sorafenib resistance in hepatocellular carcinoma","volume":"22","author":"Wang","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117058_bb0140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3892\/ijo.2013.2033","article-title":"Triptolide induces apoptosis of PMA-treated THP-1 cells through activation of caspases, inhibition of NF-\u03baB and activation of MAPKs","volume":"43","author":"Park","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"13\u201314","key":"10.1016\/j.intimp.2026.117058_bb0145","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.intimp.2005.06.009","article-title":"(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo","volume":"5","author":"Zhou","year":"2005","journal-title":"Int. Immunopharmacol."},{"issue":"13\u201314","key":"10.1016\/j.intimp.2026.117058_bb0150","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.intimp.2005.06.010","article-title":"Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells","volume":"5","author":"Tang","year":"2005","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117058_bb0155","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.juro.2014.09.007","article-title":"Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells","volume":"193","author":"Ho","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.intimp.2026.117058_bb0160","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.biopha.2018.05.088","article-title":"Broad targeting of triptolide to resistance and sensitization for cancer therapy","volume":"104","author":"Hou","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.intimp.2026.117058_bb0165","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41401-023-01219-y","article-title":"Targeted inhibition of the HNF1A\/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.intimp.2026.117058_bb0170","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1007\/s00210-025-03809-5","article-title":"Pharmacological, computational, and mechanistic insights into triptolide's role in targeting drug-resistant cancers","volume":"398","author":"Hussain","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13046-021-01995-7","article-title":"Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-\u0399\u0399","volume":"40","author":"Cai","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117058_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109232","article-title":"Triptriolide antagonizes triptolide-induced nephrocyte apoptosis via inhibiting oxidative stress in vitro and in vivo","volume":"118","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"39","key":"10.1016\/j.intimp.2026.117058_bb0185","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1002\/anie.201606121","article-title":"Targeted delivery and sustained antitumor activity of triptolide through glucose conjugation","volume":"55","author":"He","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0190","first-page":"291","article-title":"Triptolide exerts an anti-tumor effect on non-small cell lung cancer cells by inhibiting activation of the IL-6\/STAT3 axis","volume":"44","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117058_bb0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3727\/096504013X13657689382932","article-title":"Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF","volume":"20","author":"Ma","year":"2013","journal-title":"Oncol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.117058_bb0200","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1021\/nn502074x","article-title":"pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma","volume":"8","author":"Ling","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.117058_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103301","article-title":"A circular network of coregulated sphingolipids dictates lung cancer growth and progression","volume":"66","author":"Meng","year":"2021","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.intimp.2026.117058_bb0210","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.intimp.2026.117058_bb0215","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28574","article-title":"Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis","volume":"64","author":"Sun","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.117058_bb0220","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.freeradbiomed.2020.09.008","article-title":"Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway","volume":"160","author":"Li","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117058_bb0225","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","article-title":"RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells","volume":"16","author":"Zhang","year":"2020","journal-title":"Autophagy"},{"issue":"30","key":"10.1016\/j.intimp.2026.117058_bb0230","article-title":"Targeting GPX4 to induce ferroptosis overcomes chemoresistance mediated by the PAX8-AS1\/GPX4 axis in intrahepatic cholangiocarcinoma","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","article-title":"Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis","volume":"27","author":"Chen","year":"2020","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.intimp.2026.117058_bb0240","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.intimp.2026.117058_bb0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine metabolism in Cancer: understanding the heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12951-024-02574-6","article-title":"Glutathione-depleting liposome adjuvant for augmenting the efficacy of a glutathione covalent inhibitor oridonin for acute myeloid Leukemia therapy","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2026.117058_bb0255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117058_bb0260","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"12","key":"10.1016\/j.intimp.2026.117058_bb0265","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","article-title":"Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.intimp.2026.117058_bb0270","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10495-009-0397-8","article-title":"Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis","volume":"14","author":"Aroui","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2026.117058_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111565","article-title":"Ceramide glycosylation and related enzymes in cancer signaling and therapy","volume":"139","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2026.117058_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041396","article-title":"Ceramide Kinase is upregulated in metastatic breast Cancer cells and contributes to migration and invasion by activation of PI 3-Kinase and Akt","volume":"21","author":"Schwalm","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12935-020-01735-5","article-title":"Ceramide kinase mediates intrinsic resistance and inferior response to chemotherapy in triple-negative breast cancer by upregulating Ras\/ERK and PI3K\/Akt pathways","volume":"21","author":"Zhu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2026.117058_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118268","article-title":"The PPAR\u03b2\/CERK\/C1P signaling pathway is a potential mechanism by which antimony exposure promotes prostate cancer cell proliferation","volume":"297","author":"Shi","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.intimp.2026.117058_bb0295","doi-asserted-by":"crossref","first-page":"1235656","DOI":"10.3389\/fphys.2023.1235656","article-title":"The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117058_bb0300","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1164\/rccm.202001-0180OC","article-title":"Recombinant acid ceramidase reduces inflammation and infection in cystic fibrosis","volume":"202","author":"Gardner","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2026.117058_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellsig.2018.11.008","article-title":"Phosphorylation and inhibition of ceramide kinase by protein kinase C-\u03b2: their changes by serine residue mutations","volume":"54","author":"Takahashi","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2026.117058_bb0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-7091-1368-4_8","article-title":"The role of ceramide-1-phosphate in biological functions","volume":"215","author":"Hoeferlin","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117058_bb0315","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2026.117058_bb0320","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.freeradbiomed.2023.09.004","article-title":"TFEB regulates cellular labile iron and prevents ferroptosis in a TfR1-dependent manner","volume":"208","author":"Chen","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"Pt 2","key":"10.1016\/j.intimp.2026.117058_bb0325","article-title":"Advancing glioblastoma treatment through iron metabolism: a focus on TfR1 and ferroptosis innovations","volume":"278","author":"Caverzan","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117058_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104533","article-title":"Pharmacological inhibition of sphingolipid synthesis reduces ferroptosis by stimulating the HIF-1 pathway","volume":"25","author":"Liu","year":"2022","journal-title":"iScience"},{"issue":"17","key":"10.1016\/j.intimp.2026.117058_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178374","article-title":"Role of ceramide Kinase\/C1P in the regulation of cell growth and survival","volume":"26","author":"Gomez-Larrauri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117058_bb0340","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0345","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-019-0794-6","article-title":"Emerging agents and regimens for hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.intimp.2026.117058_bb0350","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4155\/fmc-2018-0108","article-title":"Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780\/CP70 via hsa-mir-6751","volume":"10","author":"Wang","year":"2018","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2026.117058_bb0355","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/aps.2017.170","article-title":"CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats","volume":"39","author":"Xu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.intimp.2026.117058_bb0360","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.28583","article-title":"Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-\u03baB downregulation","volume":"134","author":"Liu","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010227","article-title":"Implication of ceramide Kinase\/C1P in Cancer development and progression","volume":"14","author":"Camacho","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.intimp.2026.117058_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14184496","article-title":"Ceramide kinase (CERK) emerges as a common therapeutic target for triple positive and triple negative breast Cancer cells","volume":"14","author":"Rajput","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000528869","article-title":"Inhibition of ceramide Kinase is effective against cisplatin-resistant ovarian Cancer cells by regulating ceramide and C1P levels","volume":"88","author":"Zou","year":"2023","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.intimp.2026.117058_bb0380","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bcp.2018.09.017","article-title":"Pancreatic ductal adenocarcinoma cell secreted extracellular vesicles containing ceramide-1-phosphate promote pancreatic cancer stem cell motility","volume":"156","author":"Kuc","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117058_bb0385","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/humrep\/deae268","article-title":"Sphingolipids modulate redox signalling during human sperm capacitation","volume":"40","author":"Serafini","year":"2025","journal-title":"Hum. Reprod."},{"issue":"15","key":"10.1016\/j.intimp.2026.117058_bb0390","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1111\/j.1742-4658.2008.06527.x","article-title":"Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes","volume":"275","author":"Tsuji","year":"2008","journal-title":"FEBS J."},{"issue":"12","key":"10.1016\/j.intimp.2026.117058_bb0395","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201800413RR","article-title":"Deletion of the stress-response protein REDD1 promotes ceramide-induced retinal cell death and JNK activation","volume":"32","author":"Dai","year":"2018","journal-title":"FASEB J."},{"issue":"15","key":"10.1016\/j.intimp.2026.117058_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158270","article-title":"Sphingosine 1-phosphate stimulates ER to Golgi ceramide traffic to promote survival in T98G glioma cells","volume":"25","author":"Giussani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2026.117058_bb0405","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1541-7786.MCR-22-0085","article-title":"Ceramide Kinase inhibition drives ferroptosis and sensitivity to cisplatin in mutant KRAS lung Cancer by dysregulating VDAC-mediated mitochondria function","volume":"20","author":"Vu","year":"2022","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117058_bb0410","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13567","article-title":"Co-treatment with triptolide and RSL3 induces hepatocellular carcinoma cell apoptosis and ferroptosis","volume":"32","author":"Liu","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2026.117058_bb0415","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2025.02.001","article-title":"Triptolide alleviates acute lung injury by reducing mitochondrial dysfunction mediated ferroptosis through the STAT3\/p53 pathway","volume":"230","author":"Zhou","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.117058_bb0420","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3892\/ijo_00000769","article-title":"Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway","volume":"37","author":"Kim","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2026.117058_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109993","article-title":"Triptolide reduces PD-L1 through the EGFR and IFN-\u03b3\/IRF1 dual signaling pathways","volume":"118","author":"Xie","year":"2023","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:54:27Z","timestamp":1786323267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":85,"alternative-id":["S1567576926009045"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117058","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triptolide enhances lenvatinib sensitivity in hepatocellular carcinoma by regulating CERK-mediated sphingolipid-ferroptosis axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117058"}}